A panel of advisers to the US Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
US FDA advisers vote in favor of booster for J&J COVID-19 vaccine
By REUTERS
03/19/2024 03:10 AM
By REUTERS
03/19/2024 02:42 AM
By REUTERS
03/19/2024 01:15 AM
By REUTERS
03/18/2024 11:37 PM
By REUTERS
03/18/2024 10:18 PM
By REUTERS
03/18/2024 08:40 PM
By REUTERS
03/18/2024 07:55 PM
By REUTERS
03/18/2024 02:45 PM
By REUTERS
03/18/2024 01:36 PM